Cassava Sciences, Alzheimer
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.
Drug development should focus on the disease’s causal pathways rather than consequences.
Boston researchers say they’ve created a promising AI model that predicts the likelihood of someone developing Alzheimer’s ...
As the F.D.A. considers a new Alzheimer’s medication, we asked experts how the rollout of a similar drug has gone. By Dana G. Smith Over the last three years, a new class of Alzheimer’s drug ...
Journal Editorial Report: The week's best and worst from Bill McGurn, Allysia Finley, Mene Ukueberuwa and Dan Henninger. Image: Cristobal Herrera-Ulashkevich ...
Federal health advisers have endorsed a closely watched Alzheimer’s drug from Eli Lilly for people with mild dementia WASHINGTON -- A closely watched Alzheimer's drug from Eli Lilly won the ...
In a promising study for Alzheimer's disease, scientists in Japan say they have reversed the signs of this debilitating ...
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers Monday, setting the stage for the treatment's expected approval for people with mild dementia caused ...
Hoau-Yan Wang, a 67-year-old tenured medical professor, was indicted this week for an alleged scheme involving fraudulent ...